Get started
Author

Martina Falconi

Observed names: Falconi, Martina, Martina FALCONI
ORCID: 0009-0005-3263-9030
Observed ORCIDs: 0009-0005-3263-9030, 0009-0009-7122-0952
OpenAlex ID: A5083643384
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer
2023 · Alessio Cortellini, Antonio D'Alessio, et al. · Clinical Cancer Research · 84
PDF
The Influence of Overweight and Obesity on Treatment Response in Juvenile Idiopathic Arthritis
2019 · Teresa Giani, Salvatore De Masi, et al. · Frontiers in Pharmacology · 23
PDF
Ethical and Regulatory Frameworks for Artificial Intelligence in Clinical Research: A European Perspective on the Artificial Intelligence Act for Ethics Committees and Researchers
2026 · Andrea Barucci, Valentina Colcelli, et al. · European Cardiology Review · 20
PDF
The management of pediatric severe traumatic brain injury: Italian Guidelines
2021 · Leonardo BUSSOLIN, Guideline Working Group, et al. · Minerva Anestesiologica · 6
PDF
Supplementary Methods S1 from Type 2 diabetes mellitus and efficacy outcomes from imune checkpoint blockade in patients with cancer
2024 · Alessio Cortellini, Antonio D'Alessio, et al. · 1
Supplementary Table S6 from Type 2 diabetes mellitus and efficacy outcomes from imune checkpoint blockade in patients with cancer
2024 · Alessio Cortellini, Antonio D'Alessio, et al. · 1
Le sfide degli algoritmi opachi e della governance dei dati per i Comitati Etici territoriali Raccomandazioni per la valutazione di studi clinici e farmacologici basati su IA
2026 · COLCELLI, VALENTINA, Barucci, Andrea, et al. · Zenodo (CERN European Organization for Nuclear Research)
Le sfide degli algoritmi opachi e della governance dei dati per i comitati etici territoriali. Raccomandazioni per la redazione e valutazione di protocollo di studio
2026 · COLCELLI, VALENTINA, Barucci, Andrea, et al. · Zenodo (CERN European Organization for Nuclear Research)
Supplementary Figure S5 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer
2025 · Alessio Cortellini, Antonio D'Alessio, et al.
Supplementary Figure S8 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer
2025 · Alessio Cortellini, Antonio D'Alessio, et al.
Supplementary Methods S1 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer
2025 · Alessio Cortellini, Antonio D'Alessio, et al.
Supplementary Table S1 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer
2025 · Alessio Cortellini, Antonio D'Alessio, et al.
Supplementary Figure S7 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer
2025 · Alessio Cortellini, Antonio D'Alessio, et al.
Supplementary Figure S2 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer
2025 · Alessio Cortellini, Antonio D'Alessio, et al.
Supplementary Figure S1 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer
2025 · Alessio Cortellini, Antonio D'Alessio, et al.
Supplementary Figure S6 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer
2025 · Alessio Cortellini, Antonio D'Alessio, et al.
Supplementary Table S4 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer
2025 · Alessio Cortellini, Antonio D'Alessio, et al.
Supplementary Table S10 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer
2025 · Alessio Cortellini, Antonio D'Alessio, et al.
Supplementary Table S11 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer
2025 · Alessio Cortellini, Antonio D'Alessio, et al.
Supplementary Figure S3 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer
2025 · Alessio Cortellini, Antonio D'Alessio, et al.
Supplementary Table S2 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer
2025 · Alessio Cortellini, Antonio D'Alessio, et al.
Supplementary Table S7 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer
2025 · Alessio Cortellini, Antonio D'Alessio, et al.
Supplementary Table S3 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer
2025 · Alessio Cortellini, Antonio D'Alessio, et al.
Supplementary Table S8 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer
2025 · Alessio Cortellini, Antonio D'Alessio, et al.
Supplementary Table S9 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer
2025 · Alessio Cortellini, Antonio D'Alessio, et al.
Works count: 116
Citation count: 135
H-index: 4
I10-index: 3
Year
Topic
Type